Role of Chemokine & T-Cell Receptors in HIV Pathogenesis
趋化因子的作用
基本信息
- 批准号:7556689
- 负责人:
- 金额:$ 21.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:76-kDa SH2 domain-containing leukocyte proteinAcquired Immunodeficiency SyndromeAntigen ReceptorsApoptosisApoptoticBindingCCR5 geneCD4 Positive T LymphocytesCXCR4 ReceptorsCXCR4 geneCalciumCaspaseCaspase-1Cell MaturationComplexDataDevelopmentDrosophila sli proteinEventHIVHIV Envelope Protein gp120Heat shock proteinsHeat-Shock Proteins 70HomeostasisImmuneImmune System DiseasesKnowledgeLCP2 geneLeadLinkMediatingPTPRC genePathogenesisPathway interactionsPhysiological ProcessesPlayProtein-Serine-Threonine KinasesProto-Oncogene Proteins c-aktRIPK2 geneReceptor SignalingRegulationResearch DesignRoleSignal PathwaySignal TransductionSignaling MoleculeT-Cell ReceptorT-LymphocyteTherapeuticWorkapoptosis in lymphocytesbasechemokinechemokine receptorexpectationforkhead proteininnovationnovelnovel therapeuticsreceptorreceptor functiontherapeutic target
项目摘要
DESCRIPTION (provided by applicant): The HIV-envelope protein gp120 plays a critical role in triggering the apoptosis of T-lymphocytes, which is a central pathogenic feature of HIV-mediated immune dysfunction. T-cell apoptosis is also a physiological process that regulates antigen receptor repertoire selection during homeostasis and the maturation of T- cells. We hypothesize that gp120-induced cross-talk between T-cell receptor (TCR) and chemokine receptor signaling pathways leads to apoptosis. Our preliminary data on the role of the TCR signaling components CD45 and SLP-76 in HIV-gpl20-induced apoptosis support this hypothesis. In addition, we have recently shown that cross-talk between TCR and chemokine receptor CXCR4 regulates apoptosis via a novel mechanism that is mediated by AKT/Protein Kinase B (PKB), heat shock protein-70 (HSP-70), caspase-1 and RIP2 (caspase recruitment domain-containing serine/threonine kinase). To analyze mechanistically how the TCR components and chemokine receptors CXCR4/CCR5 regulate gp120-induced apoptosis, we will pursue the following specific aims: Aim 1) we will assess the interaction between CD45 and CXCR4/CCR5 signaling molecules by defining the domain of CD45 and characterizing the CD45 signaling responsible for apoptosis. Aim 2) we will perform structural and functional analyses of the TCR-mediated downstream effector SLP-76 that mediates Ca2+dependent apoptotic pathways. Aim 3) we will analyze the role of the AKT/HSP-70 apoptotic pathway that may lead to the induction of forkhead transcription factors, and will characterize the activation of caspase-1 and its regulation by RIP2. We are also exploring innovative strategies to inhibit gp120-induced apoptosis. In this regard, we have shown that a novel protein, Slit, which binds to the Robo receptor and modulates CXCR4 function can inhibit gp120-induced apoptosis. Aim 4) we will identify which domains in the Slit/Robo complex regulate the observed anti-apoptotic effects. These studies are designed to identify apoptotic signaling molecules and effector pathways involved in T-cell loss, and thus to provide novel therapeutic targets to combat immune deficiency in AIDS.
描述(由申请人提供):HIV包膜蛋白gp 120在触发T淋巴细胞凋亡中起关键作用,T淋巴细胞凋亡是HIV介导的免疫功能障碍的主要致病特征。T细胞凋亡也是在T细胞的稳态和成熟期间调节抗原受体库选择的生理过程。我们假设gp 120诱导的T细胞受体(TCR)和趋化因子受体信号通路之间的串扰导致细胞凋亡。我们关于TCR信号成分CD 45和SLP-76在HIV-gp 120诱导的细胞凋亡中的作用的初步数据支持了这一假设。此外,我们最近发现TCR和趋化因子受体CXCR 4之间的相互作用通过一种新的机制调节细胞凋亡,该机制由AKT/蛋白激酶B(PKB)、热休克蛋白-70(HSP-70)、半胱天冬酶-1和RIP 2(含半胱天冬酶募集结构域的丝氨酸/苏氨酸激酶)介导。为了分析TCR组分和趋化因子受体CXCR 4/CCR 5如何调节gp 120诱导的细胞凋亡,我们将追求以下具体目标:目的1)我们将通过定义CD 45的结构域和表征负责细胞凋亡的CD 45信号传导来评估CD 45和CXCR 4/CCR 5信号传导分子之间的相互作用。目的2)我们将对TCR介导的下游效应子SLP-76进行结构和功能分析,该效应子介导Ca 2+依赖性凋亡途径。目的3)分析AKT/HSP-70凋亡通路中可能导致叉头转录因子诱导的作用,并将表征caspase-1的激活及其受RIP 2的调节。我们也在探索创新的策略来抑制gp 120诱导的细胞凋亡。在这方面,我们已经表明,一种新的蛋白质,Slit,它结合到Robo受体和调节CXCR 4功能可以抑制gp 120诱导的细胞凋亡。目的4)我们将鉴定Slit/Robo复合物中的哪些结构域调节所观察到的抗凋亡作用。这些研究旨在鉴定参与T细胞损失的凋亡信号分子和效应子途径,从而提供新的治疗靶点以对抗艾滋病中的免疫缺陷。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ramesh K. Ganju其他文献
CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation.
非小细胞肺癌中的 CD10/NEP。
- DOI:
- 发表时间:
1994 - 期刊:
- 影响因子:15.9
- 作者:
Ramesh K. Ganju;Mary E. Sunday;Dean G. Tsarwhas;A. Card;M. Shipp - 通讯作者:
M. Shipp
MicroRNA-379-5p attenuates cancer stem cells and reduces cisplatin resistance in ovarian cancer by regulating RAD18/Polη axis
微小 RNA-379-5p 通过调节 RAD18/Polη 轴减弱卵巢癌中的癌症干细胞并降低顺铂耐药性
- DOI:
10.1038/s41419-025-07430-5 - 发表时间:
2025-02-27 - 期刊:
- 影响因子:9.600
- 作者:
Devendra Shukla;Sanjay Mishra;Tanima Mandal;Manish Charan;Ajeet Kumar Verma;Md Maqsood Ahamad Khan;Nabanita Chatterjee;Amit Kumar Dixit;Senthil Kumar Ganesan;Ramesh K. Ganju;Amit Kumar Srivastava - 通讯作者:
Amit Kumar Srivastava
Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer
- DOI:
10.1186/s12943-015-0451-9 - 发表时间:
2015-11-16 - 期刊:
- 影响因子:33.900
- 作者:
Helong Zhao;Tasha Wilkie;Yadwinder Deol;Amita Sneh;Akaansha Ganju;Mustafa Basree;Mohd W. Nasser;Ramesh K. Ganju - 通讯作者:
Ramesh K. Ganju
Ramesh K. Ganju的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ramesh K. Ganju', 18)}}的其他基金
Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer
通过定义母乳喂养与三阴性乳腺癌之间的分子联系来解决癌症差异
- 批准号:
9888345 - 财政年份:2019
- 资助金额:
$ 21.59万 - 项目类别:
Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer
通过定义母乳喂养与三阴性乳腺癌之间的分子联系来解决癌症差异
- 批准号:
10372950 - 财政年份:2019
- 资助金额:
$ 21.59万 - 项目类别:
Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer
通过定义母乳喂养与三阴性乳腺癌之间的分子联系来解决癌症差异
- 批准号:
10590700 - 财政年份:2019
- 资助金额:
$ 21.59万 - 项目类别:
Role of S100A7 in breast cancer progression and metastasis
S100A7 在乳腺癌进展和转移中的作用
- 批准号:
8526420 - 财政年份:2011
- 资助金额:
$ 21.59万 - 项目类别:
Synthetic cannabinoids as novel therapeutic strategies against non-small cell lun
合成大麻素作为非小细胞肺癌的新型治疗策略
- 批准号:
8294608 - 财政年份:2011
- 资助金额:
$ 21.59万 - 项目类别:
Role of S100A7 in breast cancer progression and metastasis
S100A7 在乳腺癌进展和转移中的作用
- 批准号:
8329625 - 财政年份:2011
- 资助金额:
$ 21.59万 - 项目类别:
Role of S100A7 in breast cancer progression and metastasis
S100A7 在乳腺癌进展和转移中的作用
- 批准号:
8777633 - 财政年份:2011
- 资助金额:
$ 21.59万 - 项目类别:
Novel approaches to attenuate lipopolysaccharide-induced inflammation
减轻脂多糖诱导的炎症的新方法
- 批准号:
8291967 - 财政年份:2011
- 资助金额:
$ 21.59万 - 项目类别:
Role of S100A7 in breast cancer progression and metastasis
S100A7 在乳腺癌进展和转移中的作用
- 批准号:
8841515 - 财政年份:2011
- 资助金额:
$ 21.59万 - 项目类别:
Role of S100A7 in breast cancer progression and metastasis
S100A7 在乳腺癌进展和转移中的作用
- 批准号:
8113028 - 财政年份:2011
- 资助金额:
$ 21.59万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 21.59万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 21.59万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 21.59万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 21.59万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 21.59万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 21.59万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 21.59万 - 项目类别:














{{item.name}}会员




